Unique Safer Medicines

Sweden, Sweden

17% Raised

Short Summary

Using unique chemical design, we discover safer drugs for the treatment of fatty liver diseases. Our lead project, the FXR agonist IOT022, shows excellent efficacy in animals. We started safety studies in Q1 2019, preparing it for testing in man.

Overview

Target
€3,500,000
Minimum
€100,000
Investment Raised
€600,000
Previous Rounds €600,000
Stage Pre-Startup/R&D
Investor Role Any

Highlights

  • IOT022 shows perfect in vivo efficacy, and drug like ADME properties
  • Ready for IND enabling studies
  • Provisional Patent Application filed.
  • Led by a team of well seasoned entrepreneurial drug hunters.
  • Excellent opportunity for high return on low investment.
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

0% raised

Treating Paralyzation

location_on Finland

A artificial inteligence software on a computer that overrides the spinal cord and converts the signals from the brain directly to the nerves that are responble for the movement and overriding some types of paralyse. This is appliable to other uses.

€ 7,000,000

Target

€ 100

Min per Investor

0% raised

Nanomedicine - The Future

location_on Sweden

We have developed a method for making biodegradable core-shell nanoparticles incorporated into a hydrogel matrix for treatment and cure of various skin diseases as well as chronic wounds. We are certain it will work as predicted.

€ 1,000,000

Target

€ 300,000

Min per Investor

Featured
37% raised

Employee Mental Health

location_on London, United Kingdom

Tlero; a clinically backed platform to empower people & improve their mental health in the workplace; trusted by the world's best businesses; Won 'People's Choice Award' at BT Better World Challenge(2018); Already raised £150k+

€ 450,000

Target

€ 34,000

Min per Investor

load one similar proposal